glp 1 agonisten New GLP-1 Guidelines for Type 2 Diabetes in 2025 GLP-1R agonist DMB

Newer options like retatrutide show even more promise in clinical trials

J.LiR.et al (2018)

Form of Glutathione The most important factor is the form used

Exclusion criteria: (1) Patients with abnormal coagulation function [limits: prothrombin time (PT) between 1014 seconds, activated partial thromboplastin time (APTT) between 2540 seconds, and fibrinogen (Fib) levels between 2.04.0 g/L] and immunodeficiency [either primary immunodeficiency (congenital or hereditary conditions leading to impaired immune responses) or secondary immunodeficiency (conditions acquired through HIV infection, chronic immunosuppressive therapy, or severe malnutrition)]